Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptor 3 (TLR3) is a type I transmembrane protein and a member of the toll-like receptor family, functioning as a key sensor of viral infection by recognizing double-stranded RNA (dsRNA). It is primarily localized to endosomal membranes and initiates innate immune responses by inducing the production of type I interferons, proinflammatory cytokines, and chemokines. Its signaling pathway involves the recruitment of the TRIF/TICAM1 adaptor protein, leading to the activation of IRF3 and NF-kB. TLR3 plays a protective role in antiviral immunity and has also been implicated in other functions such as protection against atherosclerosis, ischemic preconditioning-induced protection against brain ischemia, and promotion of hair follicle regeneration. Dysregulation of TLR3 can contribute to autoimmune conditions, and it is being investigated as a therapeutic target for cancer immunotherapy.
Activation of TRIF/TICAM1, leading to IRF3 and NF-kB activation, resulting in type I interferon and inflammatory cytokine production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 3 (TLR3).